Authors: Maertens, G Priem, S Ducatteeuw, A Verschoorl, E Verstrepen, B Roskams, T Desmet, V Fuller, S Van Hoek, K Vandeponseele, P Bosman, F Buyse, MA van Doorn, LJ Heeney, J Kos, A Depla, E

Citation: G. Maertens et al., Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 protein, ACT GASTR B, 63(2), 2000, pp. 203-203

Authors: Verschoor, EJ Davis, D van Gils, M Koopman, G Mooij, P Oostermeijer, H Ten Haaft, P Verstrepen, B Rosenwirth, B Morein, B Barnett, SW Heeney, JL

Citation: Ej. Verschoor et al., Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus, J MED PRIM, 28(4-5), 1999, pp. 224-232

Authors: Verschoor, EJ Mooij, P Oostermeijer, H van der Kolk, M ten Haaft, P Verstrepen, B Sun, YD Morein, B Akerblom, L Fuller, DH Barnett, SW Heeney, JL

Citation: Ej. Verschoor et al., Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in rhesus macaques: Evidence for viral clearance, J VIROLOGY, 73(4), 1999, pp. 3292-3300